PURPOSE: To report a case of lead exposure in a 10-year-old girl which resulted in a supranormal ERG and clinical findings of decreased visual acuity, color vision, and stereopsis. METHOD: Case report. RESULTS: A 10-year-old girl was exposed to unknown levels of lead, with peak recorded blood levels of 19 mcg/dl 5 years prior to presentation. Lead levels had since normalized. Uncorrected visual acuity was 20/200-OU, improving to 20/80-OU with a refractive correction of +1.50 + 0.75 x 90 degrees OD, +2.50 sphere OS. Color vision was tested with Ishihara plates, and appeared markedly impaired. Stereopsis was grossly impaired, as the patient could not perceive stereoscopic depth with the Titmus "fly" target. Her cognitive function appeared to be slowed and her reaction time also delayed. ERG waveforms were supranormal under photopic and scotopic conditions. Implicit times were normal. CONCLUSION: Lead toxicity with significant visual and cognitive dysfunction, and supranormal ERG, can persist at lead levels below those recognized for lead poisoning.
PURPOSE: To report a case of lead exposure in a 10-year-old girl which resulted in a supranormal ERG and clinical findings of decreased visual acuity, color vision, and stereopsis. METHOD: Case report. RESULTS: A 10-year-old girl was exposed to unknown levels of lead, with peak recorded blood levels of 19 mcg/dl 5 years prior to presentation. Lead levels had since normalized. Uncorrected visual acuity was 20/200-OU, improving to 20/80-OU with a refractive correction of +1.50 + 0.75 x 90 degrees OD, +2.50 sphere OS. Color vision was tested with Ishihara plates, and appeared markedly impaired. Stereopsis was grossly impaired, as the patient could not perceive stereoscopic depth with the Titmus "fly" target. Her cognitive function appeared to be slowed and her reaction time also delayed. ERG waveforms were supranormal under photopic and scotopic conditions. Implicit times were normal. CONCLUSION: Lead toxicity with significant visual and cognitive dysfunction, and supranormal ERG, can persist at lead levels below those recognized for lead poisoning.
Authors: Stephen J Rothenberg; Lourdes Schnaas; Manuel Salgado-Valladares; Esther Casanueva; Andrew M Geller; H Kenneth Hudnell; Donald A Fox Journal: Invest Ophthalmol Vis Sci Date: 2002-06 Impact factor: 4.799
Authors: Donald A Fox; Subbarao V Kala; W Ryan Hamilton; Jerry E Johnson; James P O'Callaghan Journal: Environ Health Perspect Date: 2008-05 Impact factor: 9.031
Authors: David E Jacobs; Robert P Clickner; Joey Y Zhou; Susan M Viet; David A Marker; John W Rogers; Darryl C Zeldin; Pamela Broene; Warren Friedman Journal: Environ Health Perspect Date: 2002-10 Impact factor: 9.031
Authors: Donald A Fox; W Ryan Hamilton; Jerry E Johnson; Weimin Xiao; Shawntay Chaney; Shradha Mukherjee; Diane B Miller; James P O'Callaghan Journal: Toxicol Appl Pharmacol Date: 2011-06-12 Impact factor: 4.219
Authors: Anand Giddabasappa; W Ryan Hamilton; Shawntay Chaney; Weimin Xiao; Jerry E Johnson; Shradha Mukherjee; Donald A Fox Journal: Environ Health Perspect Date: 2010-09-14 Impact factor: 9.031
Authors: Shawnta Y Chaney; Shradha Mukherjee; Anand Giddabasappa; Elda M Rueda; W Ryan Hamilton; Jerry E Johnson; Donald A Fox Journal: Mol Vis Date: 2016-12-24 Impact factor: 2.367